4 early-career faculty members have been selected as 2016 Rising Stars, for their commitment to our values of excellence in patient care, research, education and community.
Erik Wallace, associate dean for the Colorado Springs Branch, stressed that the program is about more than attracting new talent to the region to work in primary care.
Jacinda Nicklas, says it’s crucial for women to be able to answer these seven health questions, routinely asked by doctors, or used in risk factor assessments, to help figure out if something harmless—or potentially extremely harmful—is going on.
UCHealth Memorial Hospital soon will begin playing a major role in educating the physicians of tomorrow. On May 2, students from the University of Colorado School of Medicine’s new Colorado Springs branch will begin clinical rotations at the hospital.
Medication access specialists at UCH help clinics handle the often time-consuming details of filling prescription refills and handling prior authorization requests.
Med students, staff and faculty showcase their artistic talent in send-off to choir director.
Chronic inflammation of obesity, autoimmune conditions leads to imbalanced blood system and potential cancer risk
Systemic scleroderma (SSc) is “arguably the most challenging illness” rheumatologists encounter, according to Aryeh Fischer, MD.
Catherine Lozupone, PhD, will use her award to uncover connections between the human microbiome and inflammatory disease.
"We believe that tumor shrinkage isn’t the only measure of successful cancer immunotherapy. In this case and others, the long term control of advanced colorectal cancer is a goal unto itself,” says S. Gail Eckhardt, MD, FASCO
“Receiving this award is a great honor and it really jump-starts my research here at the University of Colorado,” Sherbenou says.
A University of Colorado Cancer Center study presented at the American Association for Cancer Research Annual Meeting 2016 pinpoints ways that cancer cells evolve to resist the drug LOXO-101.
Dr. Bill Burman, director of Denver Public Health, will serve in the CEO role until the public hospital agency's leaders find a permanent successor to Dr. Arthur Gonzalez.
The word cancer is a problem, said Bryan R. Haugen, a thyroid cancer specialist at the University of Colorado, who was also not a member of the renaming panel. “If you keep cancer in there a lot of people are going to be aggressive,” he said.
“We are trying to compare four different medications when added to Metformin for glycemic control,” said Neda Rasouli, associate professor of medicine in the Division of Endocrinology at UCH.